[1]
2024. Analysis of Favipiravir Adverse Drug Reactions during COVID-19 Pandemic: A Retrospective Study Based on Iraqi Pharmacovigilance Center Database. Al Mustansiriyah Journal of Pharmaceutical Sciences. 24, 2 (Apr. 2024), 228–236. DOI:https://doi.org/10.32947/ajps.v24i2.1069.